Laboratorios Farmaceuticos Rovi, S.A. (BIT:1ROVI)
49.80
+0.26 (0.52%)
At close: Apr 16, 2025
BIT:1ROVI Revenue
In the year 2024, Laboratorios Farmaceuticos Rovi had annual revenue of 763.75M EUR, down -7.93%. Laboratorios Farmaceuticos Rovi had revenue of 199.14M in the quarter ending December 31, 2024, a decrease of -15.13%.
Revenue
763.75M
Revenue Growth
-7.93%
P/S Ratio
3.28
Revenue / Employee
347.63K
Employees
2,197
Market Cap
2.51B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 763.75M | -65.76M | -7.93% |
Dec 31, 2023 | 829.51M | 11.81M | 1.44% |
Dec 31, 2022 | 817.70M | 169.02M | 26.06% |
Dec 31, 2021 | 648.68M | 228.72M | 54.46% |
Dec 31, 2020 | 419.96M | 38.65M | 10.14% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UniCredit | 23.99B |
Intesa Sanpaolo | 25.38B |
Enel SpA | 78.95B |
Ferrari | 6.68B |
Assicurazioni Generali | 55.30B |
Eni S.p.A. | 91.17B |
Leonardo S.p.a. | 17.76B |
Stellantis | 156.88B |